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Identification of Creb3l4 as an essential negative
regulator of adipogenesis
T-H Kim1, S-H Jo1,2, H Choi1, J-M Park1, M-Y Kim1, H Nojima3, J-W Kim1 and Y-H Ahn*,1,2
Understanding the molecular networks that regulate adipogenesis is crucial for combating obesity. However, the identity and
molecular actions of negative regulators that regulate the early development of adipocytes remain poorly understood. In this study,
we investigated the role of CREB3L4, a member of the CREB3-like family, in the regulation of adiposity. Constitutive overexpression
of CREB3L4 resulted in the inhibition of adipocyte differentiation, whereas knockdown of Creb3l4 expression caused
differentiation of preadipocytes into mature adipocytes, bypassing the mitotic clonal expansion step. In 3T3-L1 preadipocytes,
Creb3l4 knockdown resulted in increased expression of peroxisome proliferator-activated receptor γ (PPARγ2) and CCAAT/
enhancer binding protein (C/EBPα), either by increasing the protein stability of C/EBPβ or by decreasing the expression of GATA3,
a negative regulator of PPARγ2 expression. Consequently, increased PPARγ2 and C/EBPα levels induced adipocyte differentiation,
even in the presence of minimal hormonal inducer. Thus, it can be speculated that CREB3L4 has a role as gatekeeper, inhibiting
adipogenesis in 3T3-L1 preadipocytes. Moreover, adipocytes of Creb3l4-knockout mice showed hyperplasia caused by increased
adipogenesis, and exhibited improved glucose tolerance and insulin sensitivity, as compared with littermate wild-type mice. These
results raise the possibility that Creb3l4 could be a useful therapeutic target in the fight against obesity and metabolic syndrome.
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Obesity is a worldwide epidemic in both developed and
developing countries. Due to excess food intake, adipose
tissue enlarges, via either hyperplasia or hypertrophy.1
Increased adipose tissue is associated closely with the
development of insulin resistance and is the principal risk
factor in the development of type 2 diabetes mellitus.2 Thus,
studying the biological networks and transcription factors
controlling adipogenesis, including adipocyte differentiation,
may facilitate greater understanding of the pathophysiology of
obesity and type 2 diabetes.
Adipogenesis is a multi-step process requiring a cascade of
transcription factors that regulate the expression of genes
involved in lipogenesis, β-oxidation, and fatty acid uptake.3
Members of the CCAAT/enhancer binding family, such as C/
EBPα, − β, and -δ, have key roles in adipogenesis.4,5 C/EBPβ
andC/EBPδ directly upregulate the expression of C/EBPα and
peroxisome proliferator-activated receptor γ (PPARγ).6 Upon
expression, PPARγ and C/EBPα cooperate to express the full
adipogenic program, including induction of additional tran-
scription factors and suppression of growth-associated
genes.7
Recently, endoplasmic reticulum (ER) membrane-bound
bZIP domain-containing transcription factors, such as cyclic
AMP-responsive element-binding protein 3(CREB3)/Luman/
LZIP, CREB3-like 1 (CREB3L1)/OASIS, BBF2H7/CREB3L2,
CREBH/CREB3L3, and CREB4/CREB3L4, were identified.8
These proteins share a region of high sequence homology
with activating transcription factor 6 (ATF6), having a
transmembrane (TM), a transcription-activation, and a bZIP
domain. CREB3L4 (also called AIbZIP, Tisp40, or ATCE1) is
expressed in human prostate tissue,9 and Creb3l4 disruption
resulted in abnormal epididymal sperm nuclei, ER stress, and
activation of caspase 12, leading to apoptosis of meiotic/
postmeiotic germ cells.10
Mouse Creb3l4 generates CREB3L4α and CREB3L4β,
which differ in their 55-residue N-terminal extension. Deletion
of the TM domain of CREB3L4 results in retention of the
protein in the nucleus.11 CREB3L4β, but not CREB3L4α,
activates transcription of ER degradation-enhancing α-man-
nosidase-like protein (Edem), which enhances unfolded
protein degradation, presumably by acting on the unfolded
protein response element (UPRE).11 The role of CREB3L4 in
ER stress is beginning to be understood, while its role in
adipocyte differentiation and obesity is unknown.
In this study, we demonstrate a novel role of CREB3L4 in
adipogenesis. We demonstrate that CREB3L4 acts as a
negative regulator of adipogenesis through dual mechanisms.
Silencing of Creb3l4 potently increases adipocyte differentia-
tion even in the presence of minimal hormonal inducer
bypassing themitotic clonal expansion (MCE) step, enhancing
the PPARγ2 expression through regulating protein stability of
C/EBPβ and GATA3 expression in vitro. Mice with deleted
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Creb3l4 showed improved metabolic parameters due to the
increase in numbers of fat cells, caused by increased
adipogenesis. These results provide a biological framework
for discovery of potential target genes, such as Creb3l4, in
obesity treatment.
Results
CREB3L4 is regulated during adipocyte differentiation.
To investigate whether the Creb-like family is involved in
energy metabolism, we first examined the expression of the
corresponding genes in various metabolic tissues of mice.
Creb3l3 is most abundantly expressed in the liver,12 but white
adipose tissue (WAT) expressed markedly more Creb3l4 as
compared with other tissues suggesting that WAT could be
one of the target tissue of CREB3L4 action (Supplementary
Figure S1). The expression of Creb3l4 in WAT led us to
explore the role of CREB3L4 in adipocyte differentiation and
the development of adiposity. Therefore, we wondered
whether CREB3L4 is a regulatory component of the
differentiation program, and whether its expression could be
regulated during differentiation. During 3T3-L1 preadipocyte
differentiation, Creb3l4 expression decreased from day 0
(D0) and recovered after D2, as shown by real-time PCR
(Figure 1a) and western blotting (Figure 1b). Fractionation of
adipose tissue into mature adipocytes (AdipoF) and the
stromal-vascular fraction (SVF) revealed that Creb3l4 was
more abundant in the SVF, which contains adipocyte
precursors (Aps), than in AdipoF (Figure 1c). To determine
which components of the differentiation cocktail were
responsible for decreased Creb3l4 expression, 3T3-L1 cells
were stimulated for 1 day with insulin (I), dexamethasone (D),
or isobutyl methylxanthine (M), alone, or in combination
(DMI). Protein level of CREB3L4 was decreased the most by
DMI treatment, followed by treatment with isobutyl methyl-
xanthine, and with dexamethasone (Figure 1d). These results
suggested that CREB3L4 may have a critical role in
adipocyte differentiation.
CREB3L4 acts as a negative regulator of adipogenesis.
We next determined whether CREB3L4 affects adipogenesis
in vitro. To investigate the function of CREB3L4, we
transfected the nuclear form of Creb3l4 (Creb3l4-N)13 into
3T3-L1 cells; these cells showed reduced oil-red O staining
(Figure 2a). Constitutive expression of Creb3l4-N in 3T3-L1
preadipocytes resulted in a decrease in C/EBPβ from D0,
with a concomitant decrease in C/EBPα and PPARγ2
expression (Figure 2b; Supplementary Figure S2). Over-
expression of Creb3l4 decreased mRNA levels of Cebpa and
Pparg2, but that of Cebpb did not change in the early stages
(Figure 2c; discussed below), suggesting that CREB3L4 has
a negative role during DMI-induced differentiation of pre-
adipocytes into adipocyte.
Suppression of Creb3l4 expression resulted in acceler-
ated adipocyte differentiation by upregulating PPARγ2
expression in 3T3-L1 preadipocytes. If CREB3L4 has a
negative role in adipogenesis in preadipocytes, then inhibition
of Creb3l4 expression should result in accelerated
Figure 1 Regulation and function of CREB3L4 during adipocyte differentiation. (a) Real-time PCR analysis of Creb3l4mRNA levels in 3T3-L1 cells treated with differentiation
cocktail (DMI: 0.5 mM 3-isobutyl-1-methylzanthine [IBMX; M], 1 μM dexamethasone [D], and 1 μg/ml of insulin [I]) (n= 3). Error bars represent mean± S.E.M., *Po0.05.
(b) Immunoblot of CREB3L4 during differentiation of 3T3-L1 preadipocytes, treated with DMI; CREB3L4-P, precursor form of CREB3L4; CREB3L4-N, nuclear form of CREB3L4.
(c) Semi-quantitative RT-PCR analysis of the expression of the Creb3l family in the SVF and the AdipoF. SVF, stromal vascular fraction; AdipoF, adipose fat fraction.
(d) Immunoblot of CREB3L4 and C/EBPβ in 3T3-L1 cells treated for 1 day with individual components of the differentiation cocktail
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differentiation into adipocytes. To test this hypothesis, we
examined the adipocyte differentiation capacity of cells under
the influence of a minimal hormonal inducer, which sup-
pressed differentiation in the scramble group (Figure 3a;
Supplementary Figure S3a). To this end, 3T3-L1 cells that had
been transfected with scramble small-interfering RNA (siRNA)
or Creb3l4-siRNA (siCreb3l4) were mock treated, or treated
with dexamethasone or insulin in Dulbecco’s modified Eagle’s
medium (DMEM) containing fetal bovine serum (10% FBS-
DMEM). The scramble group did not differentiate into
adipocytes in the presence of the minimal inducer of
differentiation, with mock, insulin, or dexamethasone treat-
ment, whereas in the absence of the inducer, the siCreb3l4
group exposed to mock treatment differentiated partially
(Supplementary Figure S3b). Furthermore, modified differen-
tiation methods were sufficient to induce adipocyte differentia-
tion in the siCreb3l4 group (Figure 3b; Supplementary Figure
S3b). siCreb3l4-transfected cells that had been cultured in the
presence of insulin showed an increase in protein levels of
adipogenic transcription factor (Figure 3c), and PPARγ2 and C/
EBPα levels were already elevated on D0. The mRNA level of
Pparg2, Cebpa, and lipogenic genes for adipocyte differentia-
tion, lxra and Pepck, were also induced in siCreb3l4-
transfected 3T3-L1 cells (Figure 3d).
To further confirm the role of CREB3L4 in adipogenesis, we
established a stable cell line expressing Creb3l4-shRNA
(shCreb3l4); these cells showed increased oil-red O staining
when cultured in the presence of insulin (Figure 3e). In addition,
shCreb3l4 cells showed increased expression of PPARγ2 and
C/EBPα at D0 (Figures 3f and g). These data indicated that
suppression of Creb3l4 could enhance the capacity of
preadipocytes to differentiate into mature adipocytes,
and therefore CREB3L4 seemed to be a critical negative
regulator, determining preadipocyte–adipocyte transition in
3T3-L1 cells.
Knockdown of Creb3l4 results in bypass of the MCE
step. Since MCE of growth-arrested preadipocytes appears
to be necessary for optimal differentiation,14 we wondered
whether increased differentiation in siCreb3l4 group with
insulin treatment underwent the MCE stage or not. To
evaluate whether the siCreb3l4 group re-entered the cell
cycle due to insulin treatment, we performed a Bromodeox-
yuridine (BrdU) incorporation assay. DMI treatment of the
scramble group resulted in active incorporation of BrdU,
whereas treatment with insulin alone or with siCreb3l4
decreased BrdU incorporation as well as the number of cells
(Figures 4a and b). Although the combination of siCreb3l4
Figure 2 CREB3L4 inhibits the adipocyte differentiation. (a) 3T3-L1 cells were transfected with Creb3l4 (N) by electroporation, after which differentiation was induced by
differentiation cocktail (DMI: 0.5 mM 3-isobutyl-1-methylzanthine [IBMX; M], 1 μM dexamethasone [D], and 1 μg/ml of insulin [I]). Oil-red O staining of 3T3-L1 cells expressing
Creb3l4 (N) at day 8 (D8), and microscopy (×20) was performed. (b) 3T3-L1 cells were transduced with lentiviral Flag-Cre3l4 (N) and harvested at the indicated times. Expression
of critical adipogenic factors, as determined by immunoblot. (c) The mRNA levels of Cebpa, Pparg2, Gata3, and Cebpb were measured by real-time PCR during 3T3-L1
differentiation. Their expression was normalized to that of the Rplp0 (36B4) control. Values are expressed as mean± S.E.M., n= 3 per group, *Po0.05
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and insulin treatment was not able to increase cell prolifera-
tion and cell number, adipocyte differentiation still occurred
(Figures 3b, 4a, and b). Treatment of DMI to induce
differentiation of 3T3-L1 preadipocytes undergo two sequen-
tial rounds of mitosis over the next 2 days.15 As illustrated in
Figure 4c, when the MCE step was skipped, scramble group
did not induce adipogenesis. However, adipogenesis in
Creb3l4 knockdown cells was intact and adipogenic
transcription factor, Pparg2 and Cebpa, was increased
compared with scramble group (Figures 4c and d). Surprisingly,
knockdown of Creb3l4 in 3T3-L1 cells resulted in bypassing
MCE during adipocyte differentiation.
Figure 3 Effect of Creb3l4 ablation on adipocyte differentiation. (a) Modified protocol for inducing adipocyte differentiation. Induction of adipogenesis using the modified
protocol in siCreb3l4-expressing 3T3-L1 cells treated with insulin (1 μg/ml)-containing media (10% FBS-DMEM) every 2 days. (b) After 8 days, the cells were stained with oil-red
O, and microscopy (×20) was performed. Microscopic views representative of three independent experiments are shown. (c) Immunoblot of adipogenic transcription factors at the
indicated time points after induction of 3T3-L1 differentiation by insulin. (d) The mRNA levels related to lipogenesis, lxra and Pepck, and adipogenesis, Pparg2 and Cebpa, were
determined by real-time PCR at D6. (e) Oil-red O staining of stable 3T3-L1 cells expressing shCreb3l4 at D8, and microscopy (×20) was performed. The 3T3-L1 cells
were transduced with lentiviral shCreb3l4 and treated with 10% FBS-DMEM media containing insulin (1 μg/ml) every 2 days. Real-time PCR (f) and immunoblot (g) of adipogenic
gene expression in 3T3-L1 cells expressing shCreb3l4 at D0. Their expression was normalized to that of the Rplp0 (36B4) control. GAPDH was used as a loading control.
Data are representative of three independent experiments. Values are expressed as mean± S.E.M., n= 3 per group, *Po0.05
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CREB3L4 increases the expression of Gata3 and regulates
protein stability of C/EBPβ. As shown in Figures 3c, f, and
g, PPARγ2 and C/EBPα levels were already elevated on D0.
Thus, we assumed that elevated expression of PPARγ and C/
EBPα in 3T3-L1 preadipocytes causes differentiation into
mature adipocytes. Then, we questioned why PPARγ2 and C/
EBPα were already increased at this time point. We
examined the possible mechanisms of action of CREB3L4,
including (1) a direct effect of CREB3L4 on the expression of
Pparg2, Cebpa, and Cebpb as a repressor; (2) induction of
expression of negative regulators by CREB3L4, which in turn
would repress Pparg2 and Cebpa expression; and (3)
regulation of C/EBPβ stability, which would affect Pparg2
and Cebpa expression (Figures 2b and c). To answer this
question, we measured the effect of CREB3L4 on the
promoter activities of Pparg2, Cebpa, and Cebpb, which
turned out to have no effect (Supplementary Figure S4a).
Furthermore, the mRNA levels of most negative regulators7 in
the Creb3l4-overexpressing group were not altered
(Supplementary Figure S4b). However, the expression of
Gata3, an important negative regulator in preadipocyte–
adipocyte transition,16 was induced in the Creb3l4-trans-
duced cells (Figures 2b, c, 5a, and b). Finally, the protein, but
not the mRNA, levels of C/EBPβ decreased in Creb3l4-
expressing 3T3-L1 cells at D0 (Figures 2b, 2c, 5a, and 5b). In
siCreb3l4-treated cells, the protein levels of PPARγ2, C/
EBPα, and C/EBPβ also increased at D0 (Figure 5c).
However, real-time PCR showed no difference in the Cebpb
mRNA levels (Figure 5d). These data suggested that
CREB3L4 may act as a negative regulator of the differentia-
tion of 3T3-L1 preadipocytes both by upregulating Gata3
expression and by decreasing the stability of C/EBPβ
protein at D0.
CREB3L4 induces the C/EBPβ ubiquitination through
protein–protein interaction. To examine the effect of
CREB3L4 on the stability of C/EBPβ, we treated Creb3l4-
transfected 3T3-L1 cells with the proteasomal inhibitor,
MG132. The Creb3l4-mediated decrease in C/EBPβ levels
was restored in cells treated with MG132 (Figure 6a).
Moreover, CREB3L4 induced the ubiquitination of C/EBPβ
(Figure 6b). Because both CREB3L4 and C/EBPβ have a
Figure 4 3T3-L1 cells transfected with siCreb3l4 bypass the mitotic clonal expansion step. (a) Immunofluorescence analysis of BrdU-labeled 3T3-L1 adipocytes. The cells
were treated with DMI or insulin and were then subjected to BrdU pulsing for 2 h (from 16 to 18 h after initiation of differentiation). The period of the BrdU pulse corresponds to the
S phase in induced cells. Representative images of fluorescence microscopy (×40 magnification). (b) Cell counts were determined at days 0 and 2 after induction of differentiation
with 10% FBS-DMEM containing DMI or insulin (1 μg/ml) after transfection of siCreb3l4. (c) Modified protocol for deletion of mitotic clonal expansion step. Induction of
adipogenesis using the modified protocol in siCreb3l4-expressing 3T3-L1 cells treated with insulin (1 μg/ml)-containing media (10% FBS-DMEM) for 2 days, and changed media
every 2 days. After 8 days, the cells were stained with oil-red O, and microscopy (×20) was performed. (d) The mRNA levels of Pparg2, Cebpa, and Creb3l4 are determined by
real-time PCR. Error bars represent mean± S.E.M., n= 3 per group, *Po0.05
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bZIP domain, we performed an immunoprecipitation assay to
investigate their interaction. As expected, CREB3L4 inter-
acted with C/EBPβ (Figure 6c; Supplementary Figure S5a),
and their interaction was confirmed using reciprocal anti-
bodies (Figure 6d). Endogenous C/EBPβ also interacted with
CREB3L4 in 3T3-L1 cells (Supplementary Figure S5b).
Subcellular fractionation of cells overexpressing the nuclear
form of CREB3L413 and C/EBPβ revealed that this protein
complex is colocalized in the nucleus (data not shown).
Interaction between CREB3L4 and C/EBPβ occurs through
their bZIP domains (Figure 6e), suggesting that CREB3L4
induced ubiquitination of C/EBPβ at D0 through protein–
protein interaction.
C/EBPβmediates upregulation of PPARγ2 by inhibition of
Creb3l4. We next determined whether C/EBPβ could
regulate expression of Pparg2 and Cebpa at D0. 3T3-L1
cells transfected with Cebpb or Cebpb/Creb3l4 were treated
with insulin-containing media every 2 days. Cebpb-trans-
fected cells were differentiated, which was inhibited by co-
transfection with Creb3l4 (Figure 7a; Supplementary Figure
S6a). Expression of PPARγ2 and C/EBPα was increased by
transfection with Cebpb, but their expression was suppressed
by co-transfection with Creb3l4 at D0 (Figure 7b;
Supplementary Figure S6b). These data are supported by
previous reports demonstrating that ectopic expression of
Cebpb in NIH-3T3 cell induced Pparg expression with
accompanying adipogenesis.17 At D0, stabilized C/EBPβ in
siCreb3l4 group directly bound to the C/EBP binding region of
Cebpa and Pparg2 gene promoter (Figures 7c and d).
To investigate the interrelationship between C/EBPβ and
CREB3L4 in the induction of PPARγ2 and C/EBPα, we
transfected 3T3-L1 cells with siCebpb and siCreb3l4. The cells
that had been transfected with siCreb3l4 showed increased
adipocyte differentiation, which was inhibited by siCebpb
(Figure 7e; Supplementary Figure S6c). In preadipocytes,
siCreb3l4-mediated induction of PPARγ2 was decreased by
Cebpb knockdown (Figure 7f), suggesting that C/EBPβ is a
mediator of siCreb3l4-induced PPARγ2 expression in preadipo-
cytes. Because a siCebpb-mediated decrease in PPARγ2
protein levels was difficult to observe at D0, we performed
quantitative real-time PCR to investigate Pparg2 mRNA levels
after treatment with siCebpb. Cebpb knockdown resulted in
decreased Pparg2 expression, even at D0 (Supplementary
Figure S6d). The siCreb3l4-mediated increase inPparg2mRNA
levels was also decreased by siCebpb (Supplementary
Figure S6d). The expression pattern of Cidec, a PPARγ-
target gene, was similar to that of Pparg2 (Supplementary
Figure S6d).
GATA3 also mediates suppression of Creb3l4-induced
PPARγ2 regulation. Furthermore, because GATA3 is known
to be a negative regulator of Pparg2 expression,16 it is possible
that downregulation of GATA3 expression by siCreb3l4
(Figure 5d) could also contribute to the upregulation of PPARγ2
at D0. To test this hypothesis, we transfected 3T3-L1 cells with
siGata3; we observed increased expression of PPARγ2, but not
that of C/EBPα (Figure 8a). In addition, the siCreb3l4-mediated
increase in Pparg2 expression was diminished by overexpres-
sion of Gata3 (Figure 8b). These data suggested that GATA3 is
another mediator upregulating Pparg2 expression when
Figure 5 CREB3L4 regulates the stability of C/EBPβ protein and Gata3 expression. (a, b) Immunoblot and real-time PCR analysis of C/EBPβ and GATA3 expression in 3T3-
L1 cells with lentivirus-mediated Creb3l4 expression at D0. (c) Immunoblot of adipogenic factors at D0 in 3T3-L1 cells transfected with siCreb3l4. (d) The mRNA levels of
transcription factors at D0 in 3T3-L1 cells transfected with siCreb3l4. Values are expressed as mean± S.E.M., n= 3 per group, *Po0.05
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Creb3l4 expression is knocked down. Taken together, these
results indicated that CREB3L4 acts as a negative regulator
that blocks adipogenesis at D0, by inducing both ubiquitination
of C/EBPβ and expression of Gata3.
Creb3l4-KO mice showed improved metabolic parameters
due to increased adipogenesis. To further confirm the
effects of CREB3L4 in adipogenesis, adipocyte differentiation
in Creb3l4 KO and WT mouse embryonic fibroblasts (MEFs)
was compared. Primary Creb3l4 KO MEFs showed an
increase in lipid accumulation and morphological differentia-
tion compared with WT MEFs at D22, even in the insulin-
containing medium (Figure 9a). To elucidate the physiological
role of Creb3l4 in adipogenesis, both WT and Creb3l4-KO
mice were fed with a 45% high-fat diet (HFD) for up to
16 weeks. There are no significant differences in body weight
and fat mass (data not shown). However, the size of
adipocyte fat cells in Creb3l4-KO mice was smaller than that
in WT mice (Figures 9b and c). The average of epididymal
adipocyte diameter in WT mice was 184 μm, in the Creb3l4-
KO mice, average of adipocyte size was smaller (151 μm)
(Figure 9c). In addition, Creb3l4-KO mice exhibited an
increased number of these small adipocytes (hyperplasia),
which may contribute to improved glucose tolerance and
insulin sensitivity (Figures 9d and e). HFD-fed Creb3l4-KO
mice showed decreased fasting glucose levels (Figure 9d)
and were resistant to diet-induced hyperinsulinemia
(Figure 9f). However, plasma lipid profiles, including triglycer-
ide, total cholesterol, and non-esterified free fatty acid levels,
were not significantly different between these groups
(Supplementary Figure S7a). Because adipose tissue can
affect systemic glucose homeostasis by secreting adipo-
kines, we measured adipokine levels. We found lower levels
of leptin, resistin, and PAI-1 in Creb3l4-KO mice than in WT
mice, suggesting that deletion of Creb3l4 led to an altered
adipokine profile that may contribute to improved insulin
sensitivity (Figure 9f). In addition, insulin-stimulated Akt
phosphorylation (S473) was augmented in WAT and liver
tissues, but not in muscle, of the Creb3l4-KO mice
(Supplementary Figure S7b). These results indicate that
adipocyte hyperplasia due to increased adipogenesis in
HFD-fed Creb3l4-KO mice could be an adaptation to over-
come glucose intolerance and insulin resistance.
Figure 6 CREB3L4 induces the C/EBPβ ubiquitination through direct interaction. (a) 3T3-L1 cells were transfected with a Creb3l4-N expression vector and treated with
MG132 (10 μM) for 4 h. C/EBPβ expression at day 0 (D0) was detected by immunoblotting. (b) NIH-3T3 cells were co-transfected with Creb3l4, Cebpb, and ubiquitin expression
vectors and then treated for 4 h with MG132 (10 μM). Subsequently, an immunoprecipitation assay was carried out. Ubiquitin-conjugated C/EBPβ was detected by
immunoblotting. (c) NIH-3T3 cells transfected with Cebpb and Creb3l4 expression vectors were immunoprecipitated using an anti-C/EBPβ antibody, or (d) their reciprocal
antibodies. (e) Mapping of the CREB3L4 domain interacting with C/EBPβ. Each domain of CREB3L4 is shown in the upper panel. NIH-3T3 cells were transfected with Creb3l4-
FL, Creb3l4-N, Creb3l4-BZIP, and Creb3l4-C with Cebpb. After incubation for 48 h, cell lysates were immunoprecipitated with anti-C/EBPβ antibody and probed with anti-Flag
antibody
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Figure 7 C/EBPβ is a mediator of CREB3L4 downregulating the expression of PPARγ2. (a) Oil-red O staining of adipocytes was performed at D8, and microscopy (×20) was
performed. 3T3-L1 cells were transfected with Cebpb or Cebpb/Creb3l4 and stimulated to differentiate with insulin (1 μg/ml)-containing media (10% FBS-DMEM) every 2 days. (b)
Immunoblot of adipogenic transcription factors in 3T3-L1 cells expressing Cebpb or Cebpb/Creb3l4 at D0. ChIP assay performed in 3T3-L1 cells that transfected with siCreb3l4 at
D0. Normal IgG was used as a negative control for immunoprecipitation. The regions amplified were − 435 to − 183 bp for Cebpa gene promoter (c) and − 493 to − 215 for
Pparg2 gene promoter (d). The quantity of immunoprecipitated DNA was normalized to total input DNA. Values are expressed as mean±S.E.M., n= 3 per group, *Po0.05. (e)
Oil-red O staining of 3T3-L1 cells transfected with siCebpb and siCreb3l4 at D8, and microscopy (×20) was performed. The cells were stimulated to differentiate as described in
(a). (f) Immunoblot of adipogenic factors in 3T3-L1 cells expressing siCebpb and siCreb3l4, at D0
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Discussion
Adipose tissue serves as an important regulator of metabolic
homeostasis, and thus, accumulation of fat depots is
associated with insulin resistance and a high risk for type 2
diabetes and metabolic syndrome.18 Studying the biological
networks and transcription factors, especially negative reg-
ulators, that control adipogenesis is important in the develop-
ment of a therapeutic strategy for obesity-associated type 2
diabetes and metabolic syndrome. In the present study, we
explored the role of CREB3L4 in adipogenesis and defined a
novel mechanism regulating initiation of adipogenesis. Sup-
pression of Creb3l4 resulted in the expression of PPARγ2 and
C/EBPα, followed by initiation of adipogenesis even in the
presence of minimal hormonal inducer in 3T3-L1 preadipo-
cytes, and induced hyperplastic WAT with the improved
metabolic parameters.
Although there was a difference in the degree of adipocyte
differentiation depending on the stimuli used, viz., insulin or
dexamethasone, adipogenesis did occur in all of the
siCreb3l4-treated groups (Figure 3b; Supplementary Figure
S3b). Because insulin is known to be a strong inducer of
lipogenic gene expression, insulin treatment of siCreb3l4- and
shCreb3l4-transfected cells resulted in accelerated adipogen-
esis, as compared with the mock- or dexamethasone-treated
group. Insulin strongly induces the expression of Add1/
Srebp1, which, in turn, promotes adipocyte differentiation by
augmenting PPARγ-mediated gene expression.19 Indeed,
ADD1/SREBP1 and PPARγ were shown to cooperate to
produce PPARγ ligand and to stimulate Pparg expression.20,21
These data suggested that CREB3L4 could be a critical
negative regulator determining preadipocyte–adipocyte tran-
sition in 3T3-L1 cells and that knockdown of this gene could
promote adipogenesis.
At D0, it seemed that elevated expression of PPARγ and C/
EBPα, by suppression ofCreb3l4, resulted in transition of 3T3-
L1 preadipocytes to mature adipocyte. These data are
supported by previous reports that demonstrated that retro-
viral expression of Pparg2 induced differentiation of cultured
fibroblasts into adipocytes, by cooperating with C/EBPα in
stimulating the adipocyte program. Moreover, PPARγ alone
can initiate the entire adipogenesis program in adipocytes.7,22
Thus, it is likely that elevation of PPARγ2 and C/EBPα due to
Creb3l4-knockdown could initiate adipogenesis by sequen-
tially inducing expression of genes that are involved in
adipocyte differentiation, even in the presence of minimal
hormonal inducer.
The increase in PPARγ2 and C/EBPα expression may have
further significance. Inhibition of Creb3l4 in 3T3-L1 preadipo-
cytes decreased BrdU incorporation and resulted in a lack of
further increase in cell number after treatment with DMI or
insulin alone, which seemed to involve increased expression
of C/EBPα and PPARγ2. C/EBPα has anti-mitotic and anti-
proliferative actions in terminally differentiating adipocytes and
myeloid cells.23,24 Ectopic and endogenous expression of
Pparg is also sufficient to cause cell-cycle arrest, by
modulating E2F phosphorylation.25 Additionally, PPARγ and
C/EBPα can promote growth arrest by upregulating the Cdk
inhibitor.26,27 Thus, PPARγ2 and C/EBPα expression by
siCreb3l4 caused adipocyte differentiation, bypassing the
MCE step for adipogenesis.
Our study collectively demonstrates that CREB3L4 tightly
controls the preadipocyte to adipocyte transition through a
dual mechanism, viz., decreasing protein stability of C/EBPβ
Figure 8 GATA3 is another mediator of CREB3L4 downregulating the expression
of PPARγ2. (a) Expression of PPARγ2 and C/EBPα in 3T3-L1 cells expressing
siGata3, at D0. (b) The mRNA levels of Pparg2, Creb3l4, and Gata3 in 3T3-L1 cells
transfected with siCreb3l4 and a CMV-mGata3-FL expression vector, at D0. Values
are expressed as mean± S.E.M., n= 3, *Po0.05. (c) In preadipocytes, CREB3L4
acts as a negative regulator of adipogenesis by both regulating the stability of C/EBPβ
protein and increasing GATA3 expression. After induction of differentiation by DMI
(DMI: 0.5 mM 3-isobutyl-1-methylzanthine [IBMX; M], 1 μM dexamethasone [D], and
1 μg/ml of insulin [I]), Creb3l4 and Gata3 expression is decreased, and increased C/
EBPβ levels initiate adipogenesis by increasing the expression of PPARγ2 and C/
EBPα. Suppression of Creb3l4 in preadipocytes induces adipogenesis by increasing
PPARγ2 expression
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through ubiquitination, and upregulation of Gata3 expression.
It was unclear why CREB3L4 induces ubiquitination of C/
EBPβ at D0. Presumably, because C/EBPβ, as a transcription
factor, induces expression of downstream adipogenic tran-
scription factors, CREB3L4may induce C/EBPβ ubiquitination
to maintain low levels of C/EBPβ to retain preadipocyte status.
CREB3L4 could induce the ubiquitination of C/EBPβ, but
further study, which E3 ligase is involved with CREB3L4, is
required to understand the ubiquitin conjugation mechanism
for C/EBPβ, including ubiquitin ligase. In addition, we
observed that knockdown of C/EBPβ expression also
decreased the expression of CREB3L4 (Figure 7f;
Supplementary Figure S6d). These data suggest that
C/EBPβ and CREB3L4 are co-regulated with each other.
Thus, there may exist positive or negative transcription factors
regulating the expression of C/EBPβ and CREB3L4, respec-
tively. Because the regulation of CREB3L4 during differentia-
tion is not known at present, molecular mechanism(s) of how
C/EBPβ downregulates CREB3L4 need to be explored.
Further studies on the interplay between C/EBPβ and
CREB3L4 may help understand their role in the adipocyte
differentiation. In addition, GATA3 expression is decreased by
treatment of siCreb3l4 in 3T3-L1 preadipocytes, resulting in
upregulation of PPARγ2, but not of C/EBPα (Figure 8a), which
indicates that GATA3 affects only Pparg2 expression. These
data are consistent with a previous report that GATA3 acts as a
negative regulator of adipocyte differentiation through
inhibition of Pparg expression, by directly binding to the
Pparg2 promoter.16 Gata3-deficient ES cells also showed
enhanced capacity of adipocyte differentiation under mini-
mally permissive hormonal condition.16 Our study suggests
that CREB3L4 could be upstream factor for Gata3 gene
expression in preadipocytes. In addition, GATA3 is capable of
forming protein complexes with either C/EBPα or C/EBPβ,
resulting in the suppression of adipocyte differentiation.28
Because GATA3, C/EBPα/β, and CREB3L4 are closely
associated with the initiation of adipogenesis, the interrelation-
ship among these molecules needs to be identified in detail to
understand the initiation of adipogenesis.
In general, adipose tissue expands by increased adipocyte
size (hypertrophy) and number (hyperplasia).29 However, it is
known that HFD-induced adipose tissue expansion is trig-
gered mainly by hypertrophy during the first month of HFD
feeding. After prolonged HFD exposure (i.e., longer than
1 month), Epi-WAT showed a high adipogenesis rate as
determined by a large number of new fat cells (hyperplasia).30
Differentiated adipocytes are post-mitotic; therefore, hyper-
plasia represents an increase in de novo adipocyte formation
(adipogenesis). Creb3l4-KO mice showed increased adipo-
genesis compared with WT littermates (Figures 9b and c),
similar to the findings observed in 3T3-L1 cells. Consequen-
tially, HFD-fed Creb3l4-KO mice exhibited improved
metabolic parameters due to the increase in adipocyte number
(Figures 9d–f).
Figure 9 Creb3l4-KO mice showed adipocyte hyperplasia, lead to improved metabolic parameters. (a) Adipogenic potential of mouse embryonic fibroblasts (MEFs) derived
from wild-type (WT) or Creb3l4-knockout (KO) mice. Cells were stained with oil-red O after treatment with insulin (10 μg/ml) and rosiglitazone (2 μM) for 6 days, followed by insulin
(1 μg/ml) for 16 days. Microscopic (×20) views representative of three independent experiments are shown. (b) Hematoxylin and eosin (H&E) staining of epididymal fat. Scale bar:
100 μm. (c) Adipocyte diameter was quantified with Image J (n= 3). (d) Oral glucose tolerance test (GTT), (e) insulin tolerance test (ITT), performed after 14 and 15 weeks,
respectively, of feeding HFD (n= 12–19). (f) Insulin level from mice was measured by ELISA ( n= 9–14 ). Leptin, resistin, and PAI-1 levels from mice fed HFD for 16 weeks were
measured by MAGPIX, using a MILLIPLEX MAP mouse magnetic bead panel (n= 6–12). Values are expressed as mean± S.E.M., *Po0.05, **Po0.01
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However, the phenotype of the Creb3l4 KO mice is mild.
BecauseCreb3l4 is expressed in other tissues, the generation
and characterization of adipocytes-specific knockout mice will
be required to determine the roles of CREB3L4 in obesity and
related metabolic diseases.
Taken together, we demonstrated a role for CREB3L4 in the
differentiation of 3T3-L1 preadipocytes, which functions as a
negative regulator, blocking adipogenesis. In these preadipo-
cytes, CREB3L4 increased the expression ofGata3 as well as
the ubiquitination of C/EBPβ, to retain the preadipocyte status
of the cells. When the cells were exposed to adipogenic
inducers (DMI), Creb3l4 expression was decreased, leading
to commencement of adipogenesis. It is likely that Creb3l4
expression determines the fate of cells to differentiate into
adipocytes (Figure 8c). Furthermore, CREB3L4 and C/EBPβ
genes express contrariwise during the differentiation
process31 and to the component of the differentiation cocktail
(Figure 1d). Turning off of CREB3L4 expression is a
prerequisite to turning on the C/EBPβ expression. Thus, it is
speculated that a balance between these proteins is critical for
adipocyte differentiation (Figure 8c). Indeed,Creb3l4-KOmice
subjected to an HFD showed increased hyperplasticWAT, due
to enhanced adipogenesis, which may contribute to overcome
HFD-induced glucose intolerance and insulin resistance.
These results raise the possibility that Creb3l4 could be a
useful therapeutic target in the fight against obesity and
metabolic syndrome.
Materials and Methods
Animal experiments and KO mice. SVF and AdipoF were isolated from
epididymal fat pads of 12-week-old C57BL/6J (C57BL/6JJmsSlc) mice. Briefly, the
fat pads were rapidly excised, finely minced, and incubated at 37 °C for 1 h with
1 mg/ml type I collagenase in Hank’s buffered salt solution containing 1% BSA,
200 nM adenosine, and 50 mg/ml glucose. After sequential filtration and
centrifugation, floating adipocytes (AdipoF) and pellet (SVF) were separated.32
Creb3l4-KO mouse embryos were purchased from RIKEN (The Institute of Physical
and Chemical Research, Ibaraki, Japan) with permission from Dr Nojima. The
Creb3l4-KO mice have been described previously.10 At 11 weeks of age, Creb3l4-
KO mice and their WT littermates were fed a 45% HFD (Research Diets, New
Brunswick, NJ, USA) for 18 weeks. To test activation of insulin signaling pathway,
mice fed HFD were fasted for 6 h and then received insulin (5 U/kg) by
intraperitoneal injection. After 5 min, the mice were killed.33,34 All the animal
experiments were approved by the Institutional Animal Care and Use Committee of
Yonsei University College of Medicine.
Glucose tolerance and insulin tolerance tests. For oral glucose
tolerance tests, mice were fasted for 16 h and then challenged with oral gavage of
glucose (2 g/kg body weight). For insulin tolerance tests, mice were fasted for 6 h
and then given an intraperitoneal injection of insulin (0.75 U/kg body weight;
Humulin R, Eli Lilly, Indianapolis, IN, USA). Blood glucose levels were measured, by
using a glucose monitor (One TOUCH Sure Step, Life Scan, Milpitas, CA, USA), in
blood drawn from the tail vein. The area under the curve of glucose was calculated
during the course of the tests.
Phenotypic evaluation of mice. Plasma insulin levels were then measured
using ELISA kits (ALPCO Immunoassays, Salem, NH, USA). Plasma adipokines
were measured using MAGPIX (Luminex, Austin, TX, USA) with MILLIPLEX MAP
mouse magnetic beads (Merck Millipore Corp., St Charles, MO, USA). Other
plasma metabolites, such as cholesterol, triacylglycerol, and NEFA were measured
by an enzymatic method using an autoanalyzer (Hitachi 7600; Hitachi Instruments,
Tokyo, Japan) as per the manufacturer’s instructions.
Cell culture and induction of differentiation. 3T3-L1 preadipocytes
were cultured in DMEM containing 10% calf serum (10% CS-DMEM), 100 U/ml
penicillin, 100 μg/ml streptomycin, and 8 μg/ml biotin, until they reached confluence,
and then the cells were maintained for an additional 2 days in the same medium.
These post-confluent cells (day 0 [D0]) were stimulated to differentiate using DMEM
containing 10% fetal bovine serum (10% FBS-DMEM), and a mixture of 0.5 mM 3-
isobutyl-1-methylxanthine, 1 μM dexamethasone, and 1 μg/ml of insulin (DMI) for
2 days. Cells were then further maintained for 2 days in 10% FBS-DMEM containing
only 1 μg/ml of insulin. After D4, the media were replaced every other day with 10%
FBS-DMEM without insulin. To suppress differentiation in the scramble group, the
adipocyte differentiation protocol was modified. Briefly, the cells were incubated with
10% FBS-DMEM containing mock (no treatment), insulin (1 μg/ml), or dexametha-
sone (1 μM), respectively, from D0, and media were changed every 2 days until D8,
while maintaining the respective hormonal stimulation. For MEF studies,
heterozygous animals were bred to generate E13.5 embryos. Primary MEFs
(passages 1–2) obtained from E13.5 embryos were grown to confluency (D0) in
10% FBS-DMEM. Adipocyte differentiation was induced by treating cells with 10%
FBS-DMEM containing insulin (10 μg/ml) and rosiglitazone (2 μM) for 6 days.
Thereafter, the cells were maintained in 10% FBS-DMEM containing only insulin
(1 μg/ml) for 16 days.
Total RNA isolation and quantitative real-time PCR. Total RNA was
isolated from mouse tissues using TRIzol reagent (Invitrogen, Carlsbad, CA, USA),
and total RNA of 3T3-L1 cells was isolated using the Easy Spin RNA extraction kit
(iNtRON, Gyeonggi-do, South Korea) according to the manufacturer’s instructions.
This RNA was used to generate cDNA using the ImProm-II Reverse Transcription
System (Promega, Madison, WI, USA). Quantitative real-time PCR (qPCR) was
performed using the Step One Real-Time PCR Systems instrumentation and
software (Applied Biosystems, Foster City, CA, USA) according to the
manufacturer’s protocol. The relative amount of mRNA in each sample was
normalized to Rplp0 (36B4) transcript levels. The sequences for the gene-specific
PCR primers are listed in Supplementary Table S1.
Western blotting. Proteins from 3T3-L1 and NIH-3T3 cells were isolated using
the Pro-Prep protein extraction solution (iNtRON) containing appropriate protease
inhibitors. The lysate was heated at 100 °C for 10 min, centrifuged for 5 min at
13 000 r.p.m. to remove the cell debris. Protein concentration was determined using
BCA protein assay (Thermo Scientific, Rockford, IL, USA). The protein (50 μg) in
each lane was subjected to sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and transferred onto nitrocellulose membranes (Whatman,
Dassel, Germany). Membranes were blocked with 5% non-fat milk and incubated
with the following primary antibodies: anti-CREB3L4 (AT1618a, Abgent Inc., San
Diego, CA, USA), anti-C/EBPβ (sc-150), anti-C/EBPα (sc-61), (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA), anti-AKT (pan) (#4691s), anti-p-AKT
(#9271s), anti-GAPDH (#2118), anti-PPARγ (#2443), anti-p-C/EBPβ (#3084) (all
from Cell Signaling, St Louis, MO, USA), anti-GATA3 (ab106625, Abcam,
Cambridge, MA, USA), anti-HA (#11583816001, Roche, Mannheim, Germany),
and anti-Flag (F3165, Sigma-Aldrich, St Louis, MO, USA), and anti-LXRα 35
antibodies. Membranes were then incubated with anti-mouse or anti-rabbit goat
horseradish peroxidase-conjugated secondary antibodies (Thermo Scientific) at a
1 : 4000 dilution, in 5% non-fat milk in PBST buffer (137 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, 2 mM KH2PO4, 0.1% Tween-20), for 1 h at room temperature.
Target proteins were visualized using an enhanced chemiluminescence detection
system (West Pico & West Dura, Thermo Scientific). The protein bands were
detected using a Fujifilm LAS-3000 Imager (FUJIFILM Corporation, Tokyo, Japan).
Ubiquitination assay. Cells were transfected with Flag-tagged Creb3l4 and
HA-tagged ubiquitin using FuGENE HP transfection reagent (Promega Corporation).
After 48 h, cells were treated with 10 μM MG132 for 4 h before harvesting, and were
then resuspended in cell lysis buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 0.2%
Triton X-100, 0.3% NP-40) containing protease-inhibitor cocktail tablets (Roche).
The lysates were centrifuged and precleared with protein G-agarose
(#05015952001, Roche), followed by a 2-h incubation with anti-C/EBPβ antibody
(Santa Cruz Biotechnology Inc.) and a 1-h incubation with protein G-agarose at 4 °
C. Beads were washed twice with washing buffer (1/3 dilution of cell lysis buffer in
phosphate-buffered saline (PBS)), and briefly centrifuged and resuspended in the
sample buffer before being subjected to SDS-PAGE.
Immunoprecipitation assay. Constructs expressing Flag-tagged Creb3l4
and Cebpb were co-transfected into NIH-3T3 cells using FuGENE HP transfection
reagent. After 48 h, cells were harvested and lysed in cold cell lysis buffer (50 mM
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Tris (pH 7.4), 150 mM NaCl, 0.2% Triton X-100, 0.3% NP-40) containing appropriate
protease inhibitors. Whole-cell lysate (800 μg) was precleared with protein
G-agarose (#05015952001, Roche) followed by incubation with anti-C/EBPβ
antibody or anti-CREB3L4 antibody for 16 h and protein G-agarose for 2 h at 4 °C.
After centrifugation, the protein G-agarose pellets were washed several times with
washing buffer (1/3 dilution of cell lysis buffer in PBS) and resuspended in sample
buffer before being subjected to SDS-PAGE.
Small-interfering RNA. RNA oligonucleotides for scramble (forward, 5′-CCU
ACGCCACCAAUUUCGUdTdT-3′) (Bioneer), mouse Creb3l4 (forward, 5′-UUUCUG
AGCAGUGUAUCAUAUUGGG-3′), mouse Gata3 (forward, 5′-CAUGAAGCUGGAG
ACGUCUCACUCU-3′), and mouse Cebpb (forward, 5′-AGUAGAAGUUGGCCAC
UUCCAUGGG-3′) (Invitrogen) were synthesized. Each siRNA (30 nM) was
transfected into appropriate experimental sets of 3T3-L1 cells using Lipofectamine
RNA iMAX (Invitrogen) for at least 48 h; cells were then lysed for RNA and protein
preparation.
Construction of plasmids. Expression constructs encoding the full-length
(FL), nuclear (N), BZIP (BZIP), and C-terminal (C) forms of mouse Creb3l4 were
PCR amplified and cloned directly into the pcDNA3.1-Flag2 vector. Similarly, the
PCR-amplified fragments of Cebpb were inserted into the BamHI/XhoI sites of an
expression vector, pcDNA3.1 mCebpb-V5/His. To construct luciferase reporters,
mouse Cebpb regions − 1951/+181 and mouse Cebpa regions − 1884/+220 were
subcloned into the KpnI/XhoI sites of pGL4.14. The mouse Pparg2 promoter
covering the region − 2000/+27 was a generous gift from Dr JW Kim.36 CMV-
mGATA3-FL, encoding the full-length mouse Gata3 was a gift from Dr GR Lee.37
HA-tagged ubiquitin expression vector was a gift from Dr HG Yoon.38 A lentiviral
expression vector, pLECE3-mCreb3l4-N, was constructed by subcloning the mouse
nuclear form of Creb3l4 into the HpaI/NotI sites of pLECE3. The lentiviral vector
pLECE3 was a kind gift from Dr KH Chun.39 The lentiviral vector pLKO.1-shRNA-
Creb3l4 (TRCN0000086183) and pLKO.1 puro Non-Target shRNA were purchased
(Sigma-Aldrich). The shRNA sequence of Creb3l4 was as follows: 5′-CCGG;G
CACCTCAAATGCTTGTCATACTCGAGTATGACAAGCATTTGAGGTGCTTTTTG-3′.
BrdU incorporation assay. BrdU labeling was performed on cells induced
to differentiate on coverslips with DMI or insulin alone, using a 5-Bromo-2′-deoxy-
uridine Labeling and Detection Kit I (Roche) according to the manufacturer’s
instructions. The coverslips were subsequently mounted for immunofluorescence
analysis.
Establishment of a stable cell line. The lentivirus particles were
generated using three plasmids, VSV (pMDG), RSV-REV, and PMDLg/pRRE, in
which 293FT cells were co-transfected with pLECE3-Flag-mCreb3l4(N) (control-
pLECE3) or pLKO.1-shRNA-Creb3l4 (control-pLKO.1 puro Non-Target shRNA). The
293FT cells were transfected using Plus-Lipofectamine transfection reagent
(Invitrogen) and the media was replaced with 10% CS-DMEM. Two days after
transfection, the cell culture media was filtered using a 0.45-μm syringe filter.
Culture media for 3T3-L1 cells were changed to a 1 : 5 mixture of viral supernatant
and fresh 10% CS-DMEM containing polybrene (H9268, Sigma-Aldrich) at a final
concentration of 8 μg/ml. After 3 days, lentivirus-infected 3T3-L1 cells were selected
using 2 μg/ml of puromycin (Sigma-Aldrich).
Chromatin immunoprecipitation assay. Chromatic immunoprecipitation
(ChIP) experiments were performed as previously described35 with 3T3-L1 cells
transfected with scramble or siCreb3l4 at D0. Briefly, protein extracts were
incubated for 15 h at 4 °C with 6 μg anti-C/EBPβ (sc-150, Santa Cruz Biotechnology
Inc.) or normal rabbit IgG (sc-2027, SantaCruz Biotechnology Inc.) antibodies.
Protein and/or DNA complexes were precipitated for 1 h at 4 °C using 60 μl of 50%
(vol/vol) protein G agarose/salmon sperm DNA slurry. DNA fragments were purified
using a PCR purification kit (28106; Qiagen, Valencia, CA, USA) and measured by
quantitative real-time PCR. All reactions were normalized relative to input activities
to account for chromatin sample preparation differences (ΔCt) and determined to
the difference between the α-C/EBPβ IP sample (ΔCt [C/EBPβ]) and α-IgG IP sample
(ΔCt [IgG]) for fold enrichment. ΔΔCt [C/EBPβ− IgG]=ΔCt [C/EBPβ]−ΔCt [IgG], Fold
change in occupancy= 2(−ΔΔCt[C/EBPβ-IgG]).40,41 The primers used for
the PCR of the promoter of C/EBP binding regions of Pparg2 gene
(F-5′-TTCAGATGTGTGATTAGGAG-3′, R-5′-AGACTTGGTACATTACAAGG), and
Cebpa gene (F-5′-TCCCTAGTGTTGGCTGGAAG-3′, R-5′-CAGTAGGATGGTGCC
TGCTG-3′).42
Electroporation of 3T3-L1 preadipocytes and transient transfection.
To maximize the transfection efficiency, 3T3-L1 preadipocytes were transfected
using an OneDrop Microporator MP-100 (Digital Bio, Seoul, South Korea). The cells
were transfected using a pipette-type Neon Transfection System according to the
manufacturer’s instruction (MPK10096, Invitrogen). The cells were electroporated at
1300 V, using two pulses with a 20-ms pulse width. NIH-3T3 cells were plated in 12-
well tissue culture dishes at a density of 2 × 105 cells/well in 1 ml DMEM. Expression
plasmids for Creb3l4 (0, 50, 100, and 200 ng), luciferase-tagged mPparg2 − 2000/
+27, mCebpb − 1951/+181, mCebpa − 1884/+220 (500 ng), and Renilla luciferase
were co-transfected using FuGENE HP Transfection Reagent (Promega) at a ratio
of 3 : 1. The total amount of transfected plasmid was adjusted to 200 ng by adding
empty vector. All luciferase experiments were performed using a Dual-Luciferase
Reporter Assay System (Promega). Luciferase activities were normalized to Renilla
luciferase activities to adjust transfection efficiency.
Hematoxylin and eosin staining. Epi-WAT was fixed with 10% neutral-
buffered formalin, embedded in paraffin, and sectioned. Hematoxylin and eosin
(H&E) staining was then performed on these sections.
Statistical analysis. Three to five experiments were performed for in vitro
studies, using triplicate replicates of each transfection. The data are represented as
means± standard error of the mean (S.E.M.). All data of in vitro and in vivo sets
were analyzed for statistical significance using non-parametric Mann–Whitney tests
and independent samples t-Test, respectively. All P-valueso0.05 were considered
as significant. Statistical analysis was performed using SPSS (IBM SPSS statistics
ver. 20; IBM Corp., Armonk, NY, USA).
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